The Biotech Startups Podcast

Philip Borden describes leaving Frazier Healthcare Partners for Harvard Business School, where the case method broadened his perspective beyond healthcare and investing. He explains why he returned to healthcare investing after graduation.

Philip Borden explains how realizing he did not want to pursue a PhD or spend his career at the lab bench led him toward venture capital. With a molecular biology degree, limited finance experience, and a list of biotech VC firms, he picked up the phone and cold-called his way into Frazier Healthcare in Seattle.

Philip Borden grew up in Plymouth, Indiana, in a family shaped by agriculture. He talks about his grandparents' farms, his father's work as an agricultural lender, and the early lessons he absorbed about local businesses and long-term relationships.

In this part of the podcast, Nathan Clark explains how Ganymede approaches data integration and automation in life sciences. He discusses why lab instruments and workflows require customized connectors, how a developer platform can help teams adapt integrations quickly, and why moving data online is only part of the challenge.

Nathan Clark walks through his work at Benchling, where he managed the Insights business intelligence product and helped develop an early machine learning effort. He explains why operational wet-lab data is fundamentally different from omics data, and why the relationships between samples, programs, instruments, locations, and people matter as much as the experimental results.